Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Recruiting

Early Phase 1

PsilocybinPsilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Sponsor:

Johns Hopkins University

Code:

NCT04123314

Conditions

Depressive Symptoms

Depression

Alzheimer Disease

Mild Cognitive Impairment

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Psilocybin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-12-24. This information was provided to ClinicalTrials.gov by Johns Hopkins University on 2025-08-19.